Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2014/08/004838
CTRI/2014/08/004838
Not yet recruiting
未知

Efficacy and safety study of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) on cotinine level and oxidative stress marker in chronic smokers having mild to moderate hyperlipidemia

Olive Lifesciences Pvt Ltd0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- chronic smokersmild to moderate hyperlipidemia

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- chronic smokers
Sponsor
Olive Lifesciences Pvt Ltd
Enrollment
60
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Olive Lifesciences Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • •Men \>20 years.
  • •Chronic cigarette/ beedi smoker (2\-3 packets/day since last 3 years or more) with mild to moderate hyperlipidemia (LDL ranging 160\-189 mg/dL, TC \>200 mg/dL and/or HDL\-C \<40 mg/dL).
  • •Being mentally competent and able to understand all study requirements and sign the informed consent form.

Exclusion Criteria

  • •Patients with Chronic obstructive pulmonary disease (COPD).
  • •Patients with severe liver, renal, cardiac or brain diseases.
  • •Unable to complete follow up.
  • •Subjects on any medication like diuretics.
  • •Allergic to any medication.
  • •With a history of alcohol and/or drug abuse.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate HyperlipidemiaChronic SmokersHyperlipidemia
NCT02100202Olive Lifesciences Pvt Ltd60
Unknown
Not Applicable
Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate HyperlipidemiaChronic SmokersHyperlipidemia
NCT02203227Olive Lifesciences Pvt Ltd60
Completed
Not Applicable
Safety and efficacy of a dietary supplement containing bovine alpha S1-casein tryptic hydrolysate and Hemerocallis fulva on sleep disorders among Japanese adultssleep disorders
JPRN-UMIN000013349DHC Corporation10
Completed
Not Applicable
Safety and efficacy of a dietary supplement containing Irvingia gabonensis extract.obesity
JPRN-UMIN000015534DHC Corporation20
Not yet recruiting
Phase 4
Effect of Nutritional Supplement Momordica Charantia in Type 2 Diabetes Mellitus
CTRI/2024/06/068929Kancherla Narasimha Abhinav Kaushal